Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$30.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 7,256 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,328 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 13,340 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 7,467 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 497 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 364 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 27,878 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 12,121 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 179 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 734 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 135 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,800 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 407 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,002 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 99 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,923 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 26,713 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 5,938 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | UTENDR | 9,573 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 12, 2025 | MRSN | Mersana Therapeutics, Inc. | SSELL◷ | 2,012 | $7.31 | $14.7K | -17.4% | Open the original filing on SEC.gov |
| Sep 11, 2025 | MRSN | Mersana Therapeutics, Inc. | MEXER◷◆ | 6,670 | — | — | — | Open the original filing on SEC.gov |
| Sep 11, 2025 | MRSN | Mersana Therapeutics, Inc. | MEXER◷ | 6,670 | — | — | +135.7% | Open the original filing on SEC.gov |
| May 19, 2025 | SNDX | Syndax Pharmaceuticals Inc | PBUY | 5,000 | $8.99 | $45K | +6.8% | Open the original filing on SEC.gov |